Market closedNon-fractional
Olema Pharmaceuticals/OLMA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Olema Pharmaceuticals
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Ticker
OLMA
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
San Francisco, United States
Employees
76
Website
olema.com
OLMA Metrics
BasicAdvanced
$596M
Market cap
-
P/E ratio
-$2.03
EPS
2.10
Beta
-
Dividend rate
Price and volume
Market cap
$596M
Beta
2.1
Financial strength
Current ratio
9.613
Quick ratio
9.52
Long term debt to equity
0.487
Total debt to equity
0.487
Management effectiveness
Return on assets (TTM)
-29.84%
Return on equity (TTM)
-48.31%
Valuation
Price to book
2.52
Price to tangible book (TTM)
2.52
Price to free cash flow (TTM)
-6.017
Growth
Earnings per share change (TTM)
-26.16%
3-year earnings per share growth
-4.46%
What the Analysts think about OLMA
Analyst Ratings
Majority rating from 9 analysts.
OLMA Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$31M
15.73%
Profit margin
0.00%
NaN%
OLMA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.49
-$0.48
-$0.49
-$0.56
-
Expected
-$0.73
-$0.51
-$0.48
-$0.55
-$0.57
Surprise
-32.61%
-6.11%
1.89%
2.59%
-
OLMA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Olema Pharmaceuticals stock?
Olema Pharmaceuticals (OLMA) has a market cap of $596M as of July 05, 2024.
What is the P/E ratio for Olema Pharmaceuticals stock?
The price to earnings (P/E) ratio for Olema Pharmaceuticals (OLMA) stock is 0 as of July 05, 2024.
Does Olema Pharmaceuticals stock pay dividends?
No, Olema Pharmaceuticals (OLMA) stock does not pay dividends to its shareholders as of July 05, 2024.
When is the next Olema Pharmaceuticals dividend payment date?
Olema Pharmaceuticals (OLMA) stock does not pay dividends to its shareholders.
What is the beta indicator for Olema Pharmaceuticals?
Olema Pharmaceuticals (OLMA) has a beta rating of 2.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Olema Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.